1	An	An	B-NP	DT	O	2	NMOD	-1
2	assay	assay	I-NP	NN	O	0	ROOT	-1
3	to	to	B-VP	TO	O	4	VMOD	-1
4	measure	measure	I-VP	VB	O	2	NMOD	-1
5	angiogenesis	angiogenesis	B-NP	NN	O	4	OBJ	3	angiogenesis
6	in	in	B-PP	IN	O	5	NMOD	-1
7	human	human	B-NP	JJ	O	9	NMOD	-1
8	fat	fat	I-NP	JJ	O	9	NMOD	-1
9	tissue	tissue	I-NP	NN	O	6	PMOD	-1
10	.	.	O	.	O	2	P	-1

1	BACKGROUND	BACKGROUND	B-NP	NN	O	0	ROOT	-1
2	:	:	O	:	O	1	P	-1
3	Inhibition	Inhibition	B-NP	NN	O	1	NMOD	18	Inhibition
4	of	of	B-PP	IN	O	3	NMOD	-1
5	angiogenesis	angiogenesis	B-NP	NN	O	4	PMOD	3	angiogenesis
6	reverses	reverse	B-VP	VBZ	O	3	VMOD	-1
7	rodent	rodent	B-NP	NN	O	8	NMOD	-1
8	obesity	obesity	I-NP	NN	O	6	OBJ	-1
9	.	.	O	.	O	1	P	-1

1	A	A	B-NP	DT	O	3	NMOD	-1
2	validated	validate	I-NP	VBN	O	3	NMOD	-1
3	assay	assay	I-NP	NN	O	8	SUB	-1
4	in	in	B-PP	IN	O	3	NMOD	-1
5	human	human	B-NP	JJ	O	7	NMOD	-1
6	fat	fat	I-NP	JJ	O	7	NMOD	-1
7	tissue	tissue	I-NP	NN	O	4	PMOD	-1
8	is	be	B-VP	VBZ	O	0	ROOT	-1
9	needed	need	I-VP	VBN	O	8	VC	-1
10	to	to	B-VP	TO	O	11	VMOD	-1
11	study	study	I-VP	VB	O	8	VMOD	-1
12	the	the	B-NP	DT	O	13	NMOD	-1
13	role	role	I-NP	NN	O	11	OBJ	16	role
14	of	of	B-PP	IN	O	13	NMOD	-1
15	angiogenesis	angiogenesis	B-NP	NN	O	14	PMOD	3	angiogenesis
16	in	in	B-PP	IN	O	13	NMOD	-1
17	human	human	B-NP	JJ	O	18	NMOD	-1
18	obesity	obesity	I-NP	NN	O	16	PMOD	-1
19	.	.	O	.	O	8	P	-1

1	METHODS	METHODS	B-NP	NNS	O	0	ROOT	-1
2	:	:	O	:	O	1	P	-1
3	Human	Human	B-NP	JJ	B-DNA	6	NMOD	-1
4	fat	fat	I-NP	JJ	I-DNA	6	NMOD	-1
5	tissue	tissue	I-NP	NN	I-DNA	6	NMOD	-1
6	fragments	fragment	I-NP	NNS	I-DNA	9	SUB	-1
7	from	from	B-PP	IN	O	6	NMOD	-1
8	surgery	surgery	B-NP	NN	O	7	PMOD	19	surgery
9	were	be	B-VP	VBD	O	1	NMOD	-1
10	placed	place	I-VP	VBN	O	9	VC	19	placed
11	in	in	B-PP	IN	O	10	VMOD	-1
12	96-well	96-well	B-NP	JJ	O	13	NMOD	-1
13	plates	plate	I-NP	NNS	O	11	PMOD	-1
14	,	,	O	,	O	10	P	-1
15	embedded	embed	B-VP	VBN	O	10	VMOD	19	embedded
16	in	in	B-PP	IN	O	15	AMOD	-1
17	fibrin	fibrin	B-NP	NN	O	19	NMOD	-1
18	thrombin	thrombin	I-NP	NN	O	19	NMOD	-1
19	clot	clot	I-NP	NN	O	16	PMOD	-1
20	and	and	O	CC	O	10	VMOD	-1
21	overlaid	overlay	B-VP	VBN	O	10	VMOD	19	overlaid
22	with	with	B-PP	IN	O	21	VMOD	-1
23	cell	cell	B-NP	NN	O	25	NMOD	-1
24	culture	culture	I-NP	NN	O	25	NMOD	19	culture
25	media	medium	I-NP	NNS	O	22	PMOD	-1
26	containing	contain	B-VP	VBG	O	25	NMOD	-1
27	20	20	B-NP	CD	O	28	AMOD	-1
28	%	%	I-NP	NN	O	31	NMOD	-1
29	fetal	fetal	I-NP	JJ	O	31	NMOD	-1
30	bovine	bovine	I-NP	JJ	O	31	NMOD	-1
31	serum	serum	I-NP	NN	O	26	OBJ	-1
32	.	.	O	.	O	1	P	-1

1	After	After	B-PP	IN	O	7	VMOD	-1
2	15	15	B-NP	CD	O	3	NMOD	-1
3	days	day	I-NP	NNS	O	1	PMOD	-1
4	,	,	O	,	O	7	P	-1
5	the	the	B-NP	DT	O	6	NMOD	-1
6	clots	clot	I-NP	NNS	O	7	SUB	-1
7	were	be	B-VP	VBD	O	0	ROOT	-1
8	examined	examine	I-VP	VBN	O	7	VC	-1
9	by	by	B-PP	IN	O	8	VMOD	-1
10	histology	histology	B-NP	NN	O	13	NMOD	-1
11	and	and	I-NP	CC	O	13	NMOD	-1
12	electron	electron	I-NP	NN	O	13	NMOD	-1
13	microscopy	microscopy	I-NP	NN	O	9	PMOD	-1
14	.	.	O	.	O	7	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	effect	effect	I-NP	NN	O	11	NMOD	0
3	of	of	B-PP	IN	O	2	NMOD	-1
4	taxol	taxol	B-NP	NN	O	3	PMOD	-1
5	,	,	O	,	O	11	P	-1
6	cobalt	cobalt	B-NP	NN	O	7	NMOD	-1
7	chloride	chloride	I-NP	NN	O	11	NMOD	-1
8	and	and	O	CC	O	11	NMOD	-1
9	a	a	B-NP	DT	O	11	NMOD	-1
10	heparin-steroid	heparin-steroid	I-NP	JJ	O	11	NMOD	-1
11	combination	combination	I-NP	NN	O	12	SUB	-1
12	was	be	B-VP	VBD	O	0	ROOT	-1
13	tested	test	I-VP	VBN	O	12	VC	-1
14	in	in	B-PP	IN	O	13	VMOD	-1
15	the	the	B-NP	DT	O	18	NMOD	-1
16	fat	fat	I-NP	JJ	O	18	NMOD	-1
17	tissue	tissue	I-NP	NN	O	18	NMOD	-1
18	assay	assay	I-NP	NN	O	14	PMOD	-1
19	and	and	O	CC	O	13	VMOD	-1
20	compared	compare	B-VP	VBN	O	13	VMOD	-1
21	to	to	B-PP	TO	O	20	PMOD	-1
22	the	the	B-NP	DT	O	28	NMOD	-1
23	validated	validate	I-NP	VBN	O	28	NMOD	-1
24	human	human	I-NP	JJ	O	28	NMOD	-1
25	placental	placental	I-NP	JJ	O	28	NMOD	-1
26	vein	vein	I-NP	NN	O	28	NMOD	-1
27	angiogenesis	angiogenesis	I-NP	NN	O	28	NMOD	3	angiogenesis
28	model	model	I-NP	NN	O	21	PMOD	-1
29	(	(	O	(	O	31	DEP	-1
30	HPVAM	HPVAM	B-NP	NN	B-protein	31	DEP	-1
31	)	)	O	)	O	28	NMOD	-1
32	.	.	O	.	O	12	P	-1

1	RESULTS	RESULTS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	-1
3	Blood	Blood	B-NP	NN	O	4	NMOD	-1
4	vessels	vessel	I-NP	NNS	O	5	SUB	-1
5	initiated	initiate	B-VP	VBD	O	1	NMOD	17	initiated
6	growth	growth	B-NP	NN	O	5	OBJ	4	growth
7	and	and	O	CC	O	5	VMOD	-1
8	elongated	elongate	B-VP	VBN	O	5	VMOD	4	elongated
9	from	from	B-PP	IN	O	8	VMOD	-1
10	the	the	B-NP	DT	O	13	NMOD	-1
11	fat	fat	I-NP	JJ	O	13	NMOD	-1
12	tissue	tissue	I-NP	NN	O	13	NMOD	-1
13	fragments	fragment	I-NP	NNS	O	9	PMOD	-1
14	over	over	B-PP	IN	O	8	VMOD	-1
15	15	15	B-NP	CD	O	16	NMOD	-1
16	days	day	I-NP	NNS	O	14	PMOD	-1
17	.	.	O	.	O	1	P	-1

1	Presence	Presence	B-NP	NN	O	5	SUB	0
2	of	of	B-PP	IN	O	1	NMOD	-1
3	blood	blood	B-NP	NN	O	4	NMOD	-1
4	vessels	vessel	I-NP	NNS	O	2	PMOD	-1
5	was	be	B-VP	VBD	O	0	ROOT	-1
6	confirmed	confirm	I-VP	VBN	O	5	VC	-1
7	with	with	B-PP	IN	O	6	VMOD	-1
8	histology	histology	B-NP	NN	O	11	NMOD	-1
9	and	and	I-NP	CC	O	11	NMOD	-1
10	electron	electron	I-NP	NN	O	11	NMOD	-1
11	microscopy	microscopy	I-NP	NN	O	7	PMOD	-1
12	.	.	O	.	O	5	P	-1

1	Taxol	Taxol	B-NP	NN	O	14	SUB	-1
2	at	at	B-PP	IN	O	1	NMOD	-1
3	10	10	B-NP	CD	O	8	NMOD	-1
4	(	(	O	(	O	6	DEP	-1
5	-6	-6	B-NP	CD	O	6	DEP	-1
6	)	)	O	)	O	3	NMOD	-1
7	and	and	O	CC	O	8	NMOD	-1
8	10	10	B-NP	CD	O	12	NMOD	-1
9	(	(	O	(	O	11	DEP	-1
10	-7	-7	B-NP	CD	O	11	DEP	-1
11	)	)	O	)	O	8	NMOD	-1
12	M	M	B-NP	NN	O	2	PMOD	-1
13	completely	completely	B-ADVP	RB	O	14	VMOD	-1
14	inhibited	inhibit	B-VP	VBD	O	0	ROOT	18	inhibited
15	angiogenesis	angiogenesis	B-NP	NN	O	14	OBJ	3	angiogenesis
16	,	,	O	,	O	14	P	-1
17	while	while	B-SBAR	IN	O	14	VMOD	-1
18	Taxol	Taxol	B-NP	NN	B-protein	24	NMOD	-1
19	10	10	I-NP	CD	I-protein	18	NMOD	-1
20	(	(	O	(	O	18	NMOD	-1
21	-8	-8	B-NP	CD	O	18	NMOD	-1
22	)	)	O	)	O	18	NMOD	-1
23	and	and	O	CC	O	24	NMOD	-1
24	10	10	B-NP	CD	O	28	NMOD	-1
25	(	(	O	(	O	27	DEP	-1
26	-9	-9	B-NP	CD	O	27	DEP	-1
27	)	)	O	)	O	24	NMOD	-1
28	M	M	B-NP	NN	O	31	NMOD	-1
29	and	and	O	CC	O	31	NMOD	-1
30	the	the	B-NP	DT	O	31	NMOD	-1
31	heparin-steroid	heparin-steroid	I-NP	NN	O	33	SUB	-1
32	partially	partially	B-ADVP	RB	O	33	VMOD	-1
33	inhibited	inhibit	B-VP	VBD	O	17	SBAR	18	inhibited
34	angiogenesis	angiogenesis	B-NP	NN	O	33	OBJ	3	angiogenesis
35	.	.	O	.	O	14	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	response	response	I-NP	NN	O	7	SUB	0
3	to	to	B-PP	TO	O	2	NMOD	-1
4	taxol	taxol	B-NP	NN	O	6	NMOD	-1
5	and	and	I-NP	CC	O	6	NMOD	-1
6	heparin-steroid	heparin-steroid	I-NP	NN	O	3	PMOD	-1
7	was	be	B-VP	VBD	O	0	ROOT	-1
8	similar	similar	B-ADJP	JJ	O	7	PRD	-1
9	to	to	B-PP	TO	O	8	AMOD	-1
10	that	that	B-NP	DT	O	9	PMOD	-1
11	of	of	B-PP	IN	O	10	NMOD	-1
12	the	the	B-NP	DT	O	13	NMOD	-1
13	HPVAM	HPVAM	I-NP	NN	B-protein	18	NMOD	-1
14	,	,	O	,	O	18	P	-1
15	a	a	B-NP	DT	O	18	NMOD	-1
16	validated	validate	I-NP	VBN	O	18	NMOD	-1
17	angiogenesis	angiogenesis	I-NP	NN	O	18	NMOD	3	angiogenesis
18	assay	assay	I-NP	NN	O	11	PMOD	-1
19	.	.	O	.	O	7	P	-1

1	Cobalt	Cobalt	B-NP	NN	O	2	NMOD	-1
2	chloride	chloride	I-NP	NN	O	5	NMOD	-1
3	,	,	O	,	O	5	P	-1
4	a	a	B-NP	DT	O	5	NMOD	-1
5	stimulator	stimulator	I-NP	NN	O	14	SUB	-1
6	of	of	B-PP	IN	O	5	NMOD	-1
7	vascular	vascular	B-NP	JJ	B-protein	10	NMOD	-1
8	endothelial	endothelial	I-NP	JJ	I-protein	10	NMOD	-1
9	growth	growth	I-NP	NN	I-protein	10	NMOD	0
10	factor	factor	I-NP	NN	I-protein	6	PMOD	-1
11	(	(	O	(	O	13	DEP	-1
12	VEGF	VEGF	B-NP	NN	B-protein	13	DEP	-1
13	)	)	O	)	O	10	NMOD	-1
14	stimulated	stimulate	B-VP	VBD	O	40	VMOD	17	stimulated
15	angiogenesis	angiogenesis	B-NP	NN	O	16	NMOD	3	angiogenesis
16	initiation	initiation	I-NP	NN	O	14	OBJ	17	initiation
17	at	at	B-PP	IN	O	14	VMOD	-1
18	10	10	B-NP	CD	O	22	NMOD	-1
19	(	(	O	(	O	21	DEP	-1
20	-9	-9	B-NP	CD	O	21	DEP	-1
21	)	)	O	)	O	18	NMOD	-1
22	M	M	B-NP	NN	O	17	PMOD	-1
23	in	in	B-PP	IN	O	22	NMOD	-1
24	fat	fat	B-NP	JJ	O	25	NMOD	-1
25	tissue	tissue	I-NP	NN	O	23	PMOD	-1
26	and	and	O	CC	O	40	VMOD	-1
27	the	the	B-NP	DT	O	28	NMOD	-1
28	HPVAM	HPVAM	I-NP	NN	B-protein	40	SUB	-1
29	,	,	O	,	O	40	P	-1
30	but	but	O	CC	O	40	VMOD	-1
31	at	at	B-PP	IN	O	40	VMOD	-1
32	10	10	B-NP	CD	O	36	AMOD	-1
33	(	(	O	(	O	35	DEP	-1
34	-10	-10	B-NP	CD	O	35	DEP	-1
35	)	)	O	)	O	32	NMOD	-1
36	M	M	B-NP	NN	O	39	NMOD	-1
37	blood	blood	I-NP	NN	O	39	NMOD	-1
38	vessel	vessel	I-NP	NN	O	39	NMOD	-1
39	growth	growth	I-NP	NN	O	31	PMOD	4	growth
40	was	be	B-VP	VBD	O	0	ROOT	-1
41	stimulated	stimulate	I-VP	VBN	O	40	VC	17	stimulated
42	only	only	B-ADVP	RB	O	43	PMOD	-1
43	in	in	B-PP	IN	O	41	VMOD	-1
44	the	the	B-NP	DT	O	46	NMOD	-1
45	fat	fat	I-NP	NN	O	46	NMOD	-1
46	assay	assay	I-NP	NN	O	43	PMOD	-1
47	.	.	O	.	O	40	P	-1

1	CONCLUSION	CONCLUSION	B-NP	NN	O	5	NMOD	-1
2	:	:	O	:	O	5	P	-1
3	This	This	B-NP	DT	O	5	NMOD	-1
4	angiogenesis	angiogenesis	I-NP	NN	O	5	NMOD	3	angiogenesis
5	assay	assay	I-NP	NN	O	11	SUB	-1
6	based	base	B-PP	VBN	O	5	NMOD	-1
7	on	on	B-PP	IN	O	6	PMOD	-1
8	human	human	B-NP	JJ	O	10	NMOD	-1
9	fat	fat	I-NP	JJ	O	10	NMOD	-1
10	tissue	tissue	I-NP	NN	O	7	PMOD	-1
11	uses	use	B-VP	VBZ	O	0	ROOT	-1
12	three-dimensionally	three-dimensionally	B-NP	RB	O	15	NMOD	-1
13	intact	intact	I-NP	JJ	O	15	NMOD	-1
14	human	human	I-NP	JJ	O	15	NMOD	-1
15	tissue	tissue	I-NP	NN	O	11	OBJ	-1
16	.	.	O	.	O	11	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	vessels	vessel	I-NP	NNS	O	3	SUB	-1
3	are	be	B-VP	VBP	O	0	ROOT	-1
4	derived	derive	I-VP	VBN	O	3	VC	0
5	from	from	B-PP	IN	O	4	VMOD	-1
6	quiescient	quiescient	B-NP	JJ	O	7	NMOD	-1
7	vessels	vessel	I-NP	NNS	O	5	PMOD	-1
8	within	within	B-PP	IN	O	7	NMOD	-1
9	the	the	B-NP	DT	O	10	NMOD	-1
10	fat	fat	I-NP	NN	O	8	PMOD	-1
11	.	.	O	.	O	3	P	-1

1	These	These	B-NP	DT	O	2	NMOD	-1
2	properties	property	I-NP	NNS	O	3	SUB	0
3	allow	allow	B-VP	VBP	O	0	ROOT	-1
4	the	the	B-NP	DT	O	6	NMOD	-1
5	angiogenic	angiogenic	I-NP	JJ	O	6	NMOD	3	angiogenic
6	switch	switch	I-NP	NN	O	3	OBJ	-1
7	to	to	B-VP	TO	O	8	VMOD	-1
8	be	be	I-VP	VB	O	6	NMOD	-1
9	evaluated	evaluate	I-VP	VBN	O	8	VC	-1
10	in	in	B-PP	IN	O	9	VMOD	-1
11	an	an	B-NP	DT	O	14	NMOD	-1
12	in	in	I-NP	FW	O	13	AMOD	-1
13	vitro	vitro	I-NP	FW	O	14	NMOD	-1
14	setting	setting	I-NP	NN	O	10	PMOD	-1
15	.	.	O	.	O	3	P	-1

1	The	The	B-NP	DT	O	3	NMOD	-1
2	angiogenic	angiogenic	I-NP	JJ	O	3	NMOD	3	angiogenic
3	response	response	I-NP	NN	O	7	SUB	0
4	of	of	B-PP	IN	O	3	NMOD	-1
5	fat	fat	B-NP	JJ	O	6	NMOD	-1
6	tissue	tissue	I-NP	NN	O	4	PMOD	-1
7	is	be	B-VP	VBZ	O	0	ROOT	-1
8	not	not	O	RB	O	7	VMOD	-1
9	identical	identical	B-ADJP	JJ	O	7	PRD	-1
10	to	to	B-PP	TO	O	9	AMOD	-1
11	placental	placental	B-NP	JJ	O	12	NMOD	-1
12	tissue	tissue	I-NP	NN	O	10	PMOD	-1
13	.	.	O	.	O	7	P	-1

1	This	This	B-NP	DT	O	2	NMOD	-1
2	assay	assay	I-NP	NN	O	3	SUB	-1
3	allows	allow	B-VP	VBZ	O	0	ROOT	-1
4	exploration	exploration	B-NP	NN	O	3	OBJ	17	exploration
5	of	of	B-PP	IN	O	4	NMOD	-1
6	angiogenesis	angiogenesis	B-NP	NN	O	5	PMOD	3	angiogenesis
7	in	in	B-PP	IN	O	4	NMOD	-1
8	fat	fat	B-NP	JJ	O	9	NMOD	-1
9	tissue	tissue	I-NP	NN	O	7	PMOD	-1
10	.	.	O	.	O	3	P	-1

